Sign inJoin waitlistJoin the waitlist

Abdullah Ladha

Assistant Professor · Stanford Health Care

Credentials: · · · · · · ·

History

Stanford Health Care
Present

Hematology and Medical Oncology
2010–2013
Internal Medicine
Hennepin Healthcare
2007–2010
Doctor of Medicine
2003–2007

Research

Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Journal of Clinical Oncology · 2025 · 38 citations
Mantle cell lymphoma and its management: where are we now?
Review · Experimental Hematology and Oncology · 2019 · First of 4 authors · 35 citations
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the…
Transplantation and Cellular Therapy · 2021 · 21 citations

George Yaghmour
13 papers
Eric Tam
11 papers
Karrune Woan
10 papers
Preet Chaudhary
10 papers
Lori Muffly
9 papers
BS
Bijal Shah
6 papers
Gregory Roloff
6 papers · 4 as a fellow
Ibrahim Aldoss
6 papers
Marc Schwartz
6 papers
Muthu Kumaran
6 papers
NJ
Nikeshan Jeyakumar
6 papers · 6 as a fellow
NK
Noam Kopmar
6 papers

Clinical trials

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Site PI · Recruiting · Phase 3
TScan Therapeutics, Inc.
2026–2029
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Site PI · Recruiting · Phase 1, Phase 2
Sellas Life Sciences Group
2021–2027